U.S., Aug. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07111637) titled 'Artificial Intelligence-Assisted Magnetic Resonance Imaging for Quality, Efficiency and Equity in the NHS Care of Multiple Sclerosis' on Aug. 01.
Brief Summary: Multiple Sclerosis (MS) is a long-term disease that affects over 150,000 people in the UK. Starting treatment early is important for managing MS. It is also essential to monitor the treatment to see if it is working and to switch treatments if needed.
Magnetic resonance imaging (MRI) is the only accepted tool to monitor how well the treatment is working. Current evaluation of brain MRI scans requires visual inspection, of which sensitivity is degraded by human, and technical...